A carregar...
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)
PURPOSE: Cisplatin plus 5-fluorouracil has been globally accepted as a standard regimen for the treatment for advanced gastric cancer. However, cisplatin has several disadvantages, including renal toxicity and the need for admission. S-1 plus cisplatin has become a standard treatment for advanced ga...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer Berlin Heidelberg
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3895196/ https://ncbi.nlm.nih.gov/pubmed/24366758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-013-1563-5 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|